🔗 Share this article

Chancellor Rachel Reeves has revealed she is preparing "specific action to deal with cost of living pressures" in the upcoming financial statement.

During an interview with media outlets, she emphasized that reducing inflation is a shared duty of both the administration and the Bank of England.

The UK's inflation rate is expected to be the most elevated among the Group of Seven industrialized countries this calendar year and next.

Potential Energy Bill Measures

Reports indicate the government could intervene to bring down utility costs, for example by cutting the current 5% rate of value-added tax charged on energy supplies.

A further option is to cut some of the government charges currently added to bills.

Fiscal Constraints and Analyst Expectations

The government will obtain the next assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much room there is for these actions.

The view from the majority of economists is that Reeves will have to introduce tax increases or budget cuts in order to meet her self-imposed debt limits.

Previously on the same day, calculations indicated there was a twenty-two billion pound shortfall for the Treasury chief to address, which is at the lower end of expectations.

"There's a joint task between the central bank and the government to continue tackling some of the causes of price increases," the Chancellor stated to the BBC in the US capital, at the annual meetings of the IMF and global financial institution.

Tax Commitments and International Concerns

While a great deal of the focus has been on expected tax increases, the Treasury chief said the latest information from the OBR had not changed her pledge to campaign commitments not to raise rates on earnings tax, sales tax or social security contributions.

She blamed an "unpredictable world" with increasing geopolitical and trade tensions for the Budget revenue measures, likely to be focused on those "with the broadest shoulders."

Global Economic Disputes

Referring to apprehensions about the United Kingdom's economic relations with the Asian nation she said: "Our security interests always come first."

Recent declaration by China to increase trade restrictions on rare earths and other materials that are crucial for high-technology production led American leader Donald Trump to propose an additional 100% import tax on imports from the Asian country, increasing the prospect of an full-scale commercial conflict between the two global powers.

The American finance chief described China's action "commercial pressure" and "a international production control attempt."

Inquired about accepting the American proposal to join its battle with China, Reeves said she was "deeply worried" by Chinese actions and urged the Beijing authorities "not to put up barriers and limit trade."

She said the decision was "damaging for the global economy and causes additional challenges."

"It is my opinion there are sectors where we need to challenge Chinese policies, but there are also valuable prospects to sell into China's economy, including financial services and other areas of the economic system. We've got to achieve that equilibrium correct."

The Treasury chief also stated she was working with international partners "regarding our own essential resources approach, so that we are more independent."

NHS Medicine Pricing and Investment

Reeves also admitted that the price the NHS spends on pharmaceuticals could increase as a consequence of ongoing negotiations with the US government and its pharmaceutical firms, in return for lower tariffs and investment.

A number of the world's largest drug companies have said in recent statements that they are either pausing or scrapping operations in the UK, with several blaming the modest returns they are getting.

Recently, the government science advisor said the cost the NHS pays for drugs would must go up to prevent businesses and drug research funding leaving the United Kingdom.

The Chancellor told the BBC: "It has been observed because of the cost structure, that medical research, recent pharmaceuticals have not been provided in the United Kingdom in the manner that they are in other European countries."

"We want to make sure that people receiving care from the National Health Service are can access the finest life-saving treatments in the globe. And so we are examining this situation, and... seeking to attract increased funding into Britain."